https://www.targetedonc.com/view/reactions-to-the-latest-data-on-jak-inhibition-for-myelofibrosis Who knows what the plans are? nothing in europe? Could PAC be used in the remautological space given the problem of other inhibitors? liquid shit but maybe it's better than thrombotic events